•
Sep 30, 2011

Jazz Pharmaceuticals Q3 2011 Earnings Report

Total Revenue
$73.3M
Previous year: $44.8M
+63.8%
EPS
$0.77
Previous year: $0.77
+0.0%
Gross Profit
$69.4M
Previous year: $41.7M
+66.6%
Cash and Equivalents
$101M
Previous year: $22.9M
+342.9%
Total Assets
$208M

Jazz Pharmaceuticals

Jazz Pharmaceuticals